Outliers Venture Capital

Outliers Venture Capital is a Riyadh-based operator-led firm focused on backing exceptional founders who leverage unique insights to build compounding, category-defining technology businesses across MENA. The firm writes pre-seed, seed, and Series A checks in the $1M to $5M range, with publicly disclosed bets including Tern Group and other applied AI-driven plays. Within healthcare, the firm engages with digital health and AI/ML applications, and the partner team’s operator background gives it a different posture from financial-investor peers in the Saudi market. The geographic focus is MENA with active deal flow concentrated in Saudi Arabia, the UAE, and Egypt, and the firm’s positioning emphasizes founder-quality and long-term compounding rather than thematic-trend chasing. The right founder profile is a category-defining founder with a sharp insight, technical or operational depth, and the discipline to compound over multiple years rather than chase trend cycles, ideally with early commercial traction or a working product. The wrong fit is a hype-driven me-too startup, a tourist who wants MENA capital without a real local commercial strategy, or a research-stage biotech that needs specialist diligence. The right entry path is through Riyadh and Dubai founder networks, through warm introductions from operators in the existing Outliers portfolio, through co-investors at firms like Sanabil, STV, Raed, and BECO Capital, and through the broader MENA operator community. The Outliers team is reachable through targeted outreach when the founder profile and the insight are sharp, but warm referrals materially compress diligence. When pitching, lead with the founder-market fit, the unique insight that creates the unfair advantage, and the technical or operational depth that makes the company hard to replicate. Then layer in the AI capability, commercial trajectory, and regional expansion logic. Caveats: Outliers’ healthcare-specific operating expertise is generalist rather than deep, so founders should layer clinical-domain advisors and specialist co-investors onto the cap table as the company scales. The fund’s operator-led posture also means founders should expect a hands-on partnership rather than a passive check. Use Outliers when you have a sharp insight, founder-market fit, and the discipline to build a compounding MENA-rooted technology business with global ambitions.